HemaSphere
EHA Library, EHA Delegate, 276201
New treatment strategies in multiple myeloma
EHA Library, Philippe Moreau, 273551
NGS technologies in AML: Time to use in clinical care?
EHA Library, Torsten Haferlach, 273550
ASCEND PHASE 3 STUDY OF ACALABRUTINIB VS INVESTIGATOR’S CHOICE OF RITUXIMAB PLUS IDELALISIB (IDR) OR BENDAMUSTINE (BR) IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
EHA Library, Paolo Ghia, 273259
IN STROKE-FREE CHILDREN WITH SICKLE CELL ANEMIA AND CEREBRAL VASCULOPATHY, THE OUTCOME OF STENOSIS WAS SIGNIFICANTLY BETTER AFTER TRANSPLANTATION THAN ON CHRONIC TRANSFUSION IN A PROSPECTIVE TRIAL
EHA Library, Francoise Bernaudin, 273258
EARLY HEMATOPOIESIS TRANSLATES MICROBIAL SIGNALS TO INTESTINAL TISSUE REPAIR
EHA Library, Hitoshi Takizawa, 273257
ONTOGENIC CHANGES IN HEMATOPOIETIC HIERARCHY DETERMINES PEDIATRIC SPECIFICITY AND DISEASE PHENOTYPE IN FUSION ONCOGENE-DRIVEN MYELOID LEUKEMIA
EHA Library, Cécile Lopez, 273256
DEVELOPMENT OF A CLINICAL PREDICTION RULE FOR VENOUS THROMBOEMBOLISM IN PATIENTS WITH ACUTE LEUKEMIA
EHA Library, Alejandro Lazo-Langner, 274194
IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATIC, TREATMENT-NAÏVE EALRY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): PRIMARY ENDPOINT RESULTS OF THE PHASE 3 DOUBLE-BLIND RANDOMIZED CLL12 TRIAL
EHA Library, Petra Langerbeins, 273255
A PHASE 3 STUDY OF VENETOCLAX OR PLACEBO IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
EHA Library, Shaji Kumar, 273254
HM-PRO
EHA Library, Sam Salek, 274168
CAR-T cells in MM
EHA Library, Herman Einsele, 274163
New contact system-inhibiting anticoagulant drugs that might not increase bleeding
EHA Library, Nicola Mutch, 274244
Epigenetics, DNA damage and immune modulation in the molecular landscape of AML
EHA Library, Feyruz Rassool, 273658
Early response evaluation in AML using mass cytometry
EHA Library, Bjorn Tore Gjertsen, 273659
Clinical value of new drugs in acute myeloid leukemia
EHA Library, Gert Ossenkoppele, 273660
Mechanisms of action for different checkpoint inhibitors
EHA Library, Pedro Berraondo, 273667
Invariant NKT cells as a platform for CAR immunotherapy and prevention of acute graft-versus-host disease
EHA Library, Anastasios Karadimitris, 273668
Stem cell derived NK cell therapy
EHA Library, Harry Dolstra, 273669
Follicular lymphoma genomics
EHA Library, Jessica Okosun, 273682
Novel prognostic tools that identify high risk follicular lymphoma
EHA Library, Stefano Luminari, 273683
Treatment of high risk follicular lymphoma
EHA Library, Wojciech Jurczak, 273684
NIVOLUMAB COMBINED WITH BRENTUXIMAB VEDOTIN FOR RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA: EFFICACY AND SAFETY RESULTS FROM THE PHASE 2 CHECKMATE 436 STUDY
EHA Library, Pier Luigi Zinzani, 267355
SAFETY AND EFFICACY OF COMBINATION OF SELINEXOR, DARATUMUMAB, AND DEXAMETHASONE (SDD) IN PATIENTS WITH MULTIPLE MYELOMA (MM) PREVIOUSLY EXPOSED TO PROTEASOME INHIBITORS AND IMMUNOMODULATORY DRUGS
EHA Library, Cristina J. Gasparetto, 267360
MARS: MUTATION-ADJUSTED RISK SCORE FOR ADVANCED SYSTEMIC MASTOCYTOSIS
EHA Library, Mohamad Jawhar, 267365
MEASURABLE RESIDUAL DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA (AML) WITH T(8;21)(Q22;Q22.1); RUNX1-RUNX1T1: RESULTS OF THE AML STUDY GROUP (AMLSG)
EHA Library, Frank G. Rücker, 267370
CLINICAL EFFICACY OF A NOVEL VALIDATED PROGNOSTIC INDEX FOR TRIAL DESIGN IN ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA.
EHA Library, Anthony Moorman, 267375
INCOMPLETE COUNT RECOVERY IN PATIENTS WITH COMPLETE REMISSION PRIOR TO ALLOGENEIC HCT FOR AML IS ASSOCIATED WITH A HIGH NON-RELAPSE MORTALITY WITHOUT AN INCREASED RELAPSE RISK
EHA Library, Andrew INNES, 267380
UNEXPECTED DIFFERENCES IN CARDIAC IRON METABOLISM AND SURVIVAL IN HAMP-KO AND FPN(C326S) MICE
EHA Library, Sandro Altamura, 267385
FRACTIONATED DOSING OF ARI-0001 CELLS (A3B1:CD8:4-1BB:CD3Z CAR19) AND EARLY TOCILIZUMAB ADMINISTRATION MAY REDUCE THE INCIDENCE OF SEVERE CYTOKINE RELEASE SYNDROME IN PATIENTS WITH CD19+ MALIGNANCIES
EHA Library, Valentín Ortiz-Maldonado, 267390
INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING ANTI-CD 19 CHIMERIC ANTIGEN RECEPTORS T-CELLS (CAR T) FOR DIFFUSE LARGE B CELL LYMPHOMA (DLBCL). A MONOCENTRIC PRELIMINARY EXPERIENCE.
EHA Library, Roberta Di Blasi, 267395
THE COMBINATION OF LOW ADAMTS-13 ACTIVITY AND HIGH ANTI-ADAMTS13 ANTIBODIES AT REMISSION HIGHLY PREDICTS DISEASE RELAPSE IN PATIENTS WITH ACQUIRED TTP: A MULTI-INSTITUTIONAL STUDY
EHA Library, Francesca Schieppati, 267400
REAL-WORLD RESULTS ON CD19 CAR T-CELL FOR 60 FRENCH PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA INCLUDED IN A TEMPORARY AUTHORIZATION FOR USE (ATU) PROGRAM
EHA Library, Catherine Thieblemont, 267354
HORIZON (OP-106): UPDATED EFFICACY AND SAFETY OF MELFLUFEN IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) REFRACTORY TO DARATUMUMAB (DARA) AND/OR POMALIDOMIDE (POM)
EHA Library, Paul G. Richardson, 267359
MASKED POLYCYTHEMIA VERA: ANALYSIS OF A SINGLE CENTER SERIES OF 2480 RED CELL MASSES.
EHA Library, Juliette SORET-DULPHY, 267364
SAFETY, EFFICACY, AND BIOMARKERS OF RESPONSE TO AZACITIDINE (AZA) WITH NIVOLUMAB (NIVO) AND IPILIMUMAB (IPI), AND AZA WITH NIVO IN R/R ACUTE MYELOID LEUKEMIA: A NON-RANDOMIZED, PHASE 2 STUDY.
EHA Library, Naval Daver, 267369
NELARABINE AS SALVAGE THERAPY AND BRIDGE TO ALLOGENEIC STEM CELLS TRANSPLANTATION IN 118 ADULT PATIENTS WITH RELAPSED/REFRACTORY T-ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA. A CAMPUS-ALL, PHASE 4, STUDY.
EHA Library, Anna CANDONI, 267374
REDUCTION OF GRAFT-VERSUS-HOST DISEASE USING DUAL LYMPHOCYTE SUPPRESSION WITH ANTI-THYMOCYTE GLOBULIN AND LOW-DOSE POST-TRANSPLANT CYCLOPHOSPHAMIDE IN HAPLOIDENTICAL PATIENTS AT HIGH GVHD RISK
EHA Library, Yu Wang, 267379
A PHASE IIA STUDY TO EVALUATE THE SAFETY, PK AND PD OF REPEATED ADMINISTRATIONS OF THE HEPCIDIN ANTAGONIST PRS-080 IN ANEMIC CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING HEMODIALYSIS
EHA Library, Lutz Renders, 267384
ACADEMIC, PHASE1 TRIAL ON T CELLS EXPRESSING BOTH CD19 CHIMERIC ANTIGEN RECEPTOR AND INDUCIBLE CASPASE 9 SAFETY SWITCH FOR TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA AND NON-HODGKIN LYMPHOMA
EHA Library, Francesca del bufalo, 267389
POLYMORPHISMS IN CYTOKINES, CHEMOKINES AND THEIR RECEPTORS GENES CONTRIBUTED TO CYTOMEGALOVIRUS REACTIVATION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
EHA Library, Miren Vallejo, 267394
NEUTROPHIL TO LYMPHOCYTE RATIO, PLATELET TO LYMPHOCYTE RATIO, AND RISK OF THROMBOEMBOLISM IN PATIENTS WITH LYMPHOMA RECEIVING CHEMOTHERAPY
EHA Library, Vladimir Otasevic, 267399
RITUXIMAB MAINTENANCE FOR PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN FIRST COMPLETE REMISSION: RESULTS FROM A RANDOMIZED HOVON-NORDIC LYMPHOMA GROUP PHASE III STUDY
EHA Library, Pieternella LUGTENBURG, 267353
EFFECTIVENESS OF DENOSUMAB COMPARED TO ZOLEDRONIC ACID IN BONE DISEASE TREATMENT OF MULTIPLE MYELOMA (MM): A META-ANALYSIS
EHA Library, James Abraham Malala, 267358
THREE-YEAR ANALYSIS OF THE DALIAH TRIAL - A RANDOMIZED CONTROLLED PHASE III CLINICAL TRIAL COMPARING RECOMBINANT INTERFERON ALPHA-2 VS. HYDROXYUREA IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS
EHA Library, Trine Alma Knudsen, 267363
CHROMOSOMAL ABNORMALITIES DETERMINE OUTCOME IN NPM1MUT/FLT3-ITDNEG/LOW ACUTE MYELOID LEUKEMIA
EHA Library, Linus Angenendt, 267368
BLINATUMOMAB FOR MINIMAL RESIDUAL DISEASE (MRD) IN ADULTS WITH B­CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCP­ALL): MEDIAN OVERALL SURVIVAL (OS) NOT REACHED AT 5 YEARS FOR COMPLETE MRD RESPONDERS
EHA Library, Nicola Goekbuget, 267373
A DAY 100 LAB-SCORE PREDICTS EXTENSIVE CGVHD, OVERALL SURVIVAL AND TRANSPLANT-RELATED MORTALITY AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION: FINAL ANALYSIS
EHA Library, Andrea Bacigalupo, 267378
ERFE-A260S ACCOUNTS FOR HEPATIC IRON METABOLISM IMPAIRMENT BY ACTING ON THE BMP-SMAD PATHWAY
EHA Library, Roberta Russo, 267383
A PHASE I FIRST-IN-HUMAN CLINICAL TRIAL OF CD19-TARGETED 19-28Z/4-1BBL “ARMORED” CAR T CELLS IN PATIENTS WITH RELAPSED OR REFRACTORY NHL AND CLL INCLUDING RICHTER TRANSFORMATION
EHA Library, M. Lia Palomba, 267388
SAFETY AND EFFICACY OF LIVE ATTENUATED VARICELLA VACCINE FOR PREVENTING VARICELLA ZOSTER VIRUS DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A PROSPECTIVE SINGLE-CENTER STUDY
EHA Library, Koji Kawamura, 267393
ASSOCIATION OF SYSTEMIC CYTOKINE LEVELS WITH RISK OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH GLIOMA
EHA Library, Pegah Mir Seyed Nazari, 267398
BASELINE TOTAL METABOLIC TUMOR VOLUME IS HIGHLY PROGNOSTIC FOR REFRACTORINESS TO IMMUNOCHEMOTHERAPY IN DLBCL: AN ANALYSIS OF THE PHASE 3 GOYA TRIAL
EHA Library, Marek Trneny, 267352
FIRST CLINICAL (PHASE 1B/2A) STUDY OF IBERDOMIDE (CC-220; IBER), A CELMOD, IN COMBINATION WITH DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
EHA Library, Sagar LONIAL, 267357
RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA: RESULTS FROM THE MPNSG-0212 COMBINATION TRIAL (NCT01644110)
EHA Library, Frank Stegelmann, 267362
ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION CAN ABROGATE INCREASING RISK OF RELAPSE FROM PERSISTENT MUTATIONS MEASURED BY TARGETED SEQUENCING AT REMISSION IN NORMAL KARYOTYPE ACUTE MYELOID LEUKEMIA
EHA Library, Taehyung Kim, 267367
TISAGENLECLEUCEL APPEARS EFFECTIVE AND SAFE IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA WITH HIGH-RISK CYTOGENETIC ABNORMALITIES
EHA Library, Stephan A. Grupp, 267372
INTESTINAL MICROBIOTA CAN PREDICT AGVHD FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Lijie HAN, 267377
TARGETING THE IMMUNOPHILIN FKBP12 BY DRUG REPURPOSING OR RNASE-BASED APPROACHES FOR BMP-SMAD PATHWAY AND HEPCIDIN UPREGULATION IN HEREDITARY HEMOCHROMATOSIS
EHA Library, Mariateresa Pettinato, 267382
UPDATED RESULTS FROM THE HGB-206 STUDY IN PATIENTS WITH SEVERE SICKLE CELL DISEASE TREATED UNDER A REVISED PROTOCOL WITH LENTIGLOBIN GENE THERAPY USING PLERIXAFOR-MOBILISED HAEMATOPOIETIC STEM CELLS
EHA Library, Julie Kanter, 267387
INTERRUPTING QUINOLONE PROPHYLAXIS IN HEMATOLOGIC PATIENTS WITH PROLONGED NEUTROPENIA: AN OBSERVATIONAL STUDY
EHA Library, Alvaro Bienert García, 267392
INCIDENCE, RISK FACTORS AND OUTCOMES OF THROMBOEMBOLISM EVENTS IN HAPLOIDENTICAL VS. MATCHED RELATED DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Gaochao zhang, 267397
PET-DRIVEN RADIOTHERAPY IN PATIENTS WITH LOW RISK DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) : THE DLCL10 MULTICENTER PHASE 2 TRIAL BY FONDAZIONE ITALIANA LINFOMI (FIL)
EHA Library, Monica Balzarotti, 267351
CARFILZOMIB AND DEXAMETHASONE MAINTENANCE PROLONG TIME TO PROGRESSION FOLLOWING SALVAGE ASCT IN MULTIPLE MYELOMA: A RANDOMIZED PHASE 2 TRIAL BY THE NORDIC MYELOMA STUDY GROUP
EHA Library, Henrik Gregersen, 267356
MOLECULAR ANALYSIS IN MAJIC PV CORRELATION WITH CLINICAL ENDPOINTS.
EHA Library, Natalia Curto-Garcia, 267361
MOLECULAR MRD STATUS AND OUTCOME AFTER TRANSPLANTATION IN NPM1 MUTATED AML: RESULTS FROM THE UK NCRI AML17 STUDY
EHA Library, Richard DILLON, 267366
A DASATINIB-BLINATUMOMAB COMBINATION FOR THE FRONT-LINE TREATMENT OF ADULT PH+ ALL PATIENTS. PRELIMINARY RESULTS OF THE GIMEMA LAL2116 D-ALBA TRIAL; ON BEHALF OF GIMEMA ACUTE LEUKEMIA WORKING PARTY
EHA Library, Sabina Chiaretti, 267371
TANDEM AUTOLOGOUS-REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION IN HIGH-RISK RELAPSED HODGKIN LYMPHOMA: A RETROSPECTIVE STUDY OF THE LWP-EBMT
EHA Library, Leyre Bento de Miguel, 267376
THE HEMOCHROMATOSIS PROTEINS HJV AND TFR2 ARE DISPENSABLE FOR ACUTE BMP2-MEDIATED HEPCIDIN UPREGULATION IN MICE
EHA Library, Alessia Pagani, 267381
SAFETY AND EFFICACY OF LENTIGLOBIN GENE THERAPY IN PATIENTS WITH TRANSFUSION-DEPENDENT B-THALASSAEMIA AND NON-B0/B0 GENOTYPES IN THE PHASE 3 NORTHSTAR-2 STUDY
EHA Library, Franco Locatelli, 267386
A BAL-DRIVEN ANTIMICROBIAL TREATMENT IMPROVES CLINICAL OUTCOME IN HEMATOLOGIC MALIGNANCIES PATIENTS WITH LUNG INFILTRATES DETECTION: A PROSPECTIVE MULTICENTER STUDY OF THE SEIFEM GROUP
EHA Library, Francesco MARCHESI, 267391
DEVELOPMENT OF A CLINICAL PREDICTION RULE FOR VENOUS THROMBOEMBOLISM IN PATIENTS WITH ACUTE LEUKEMIA
EHA Library, Alejandro Lazo-Langner, 267396
Neonatal leukemia
EHA Library, Irene Roberts, 274206
Management of pregnant women with inherited platelet defect
EHA Library, Patrizia Noris, 274209
Impact of stigma on psychosocial aspects of sickle cell disease
EHA Library, Kofi Anie, 273547
A NEW NEXT-GENERATION SEQUENCING STRATEGY FOR THE SIMULTANEOUS DETECTION OF GENE MUTATIONS AND COPY NUMBER VARIATIONS IN MYELOID MALIGNANCIES
EHA Library, Ramon Garcia-Sanz, 266625
IMPACT OF MINIMAL RESIDUAL DISEASE AND COMPLETE REMISSION (CR)/CR WITH PARTIAL HEMATOLOGIC RECOVERY ON SURVIVAL AFTER GILTERITINIB THERAPY IN PATIENTS WITH FLT3-MUTATED RELAPSED/REFRACTORY AML
EHA Library, Mark Levis, 266641
DETECTION OF MRD MAY PREDICT THE OUTCOME OF PATIENTS WITH ACUTE MYELOID LEUKEMIA WITH BIALLELIC CEBPA MUTATIONS
EHA Library, Jing wang, 266657
OVEREXPRESSION OF PROTEIN TYROSINE PHOSPHATASE NON-RECEPTOR TYPE1 CAUSES STAT5 DEPHOSPHORYLATION, RESULTING IN SUPPRESSION OF CELL GROWTH SIGNAL IN K562 HUMAN LEUKEMIA CELLS
EHA Library, Masayuki SHISEKI, 266950
UPDATED RISK STRATIFICATION MODEL FOR SMOLDERING MULTIPLE MYELOMA (SMM) INCORPORATING THE REVISED IMWG DIAGNOSTIC CRITERIA
EHA Library, María-Victoria Mateos, 266966
COMPREHENSIVE GENETIC ANALYSIS OF MULTIPLE MYELOMA IN JAPAN
EHA Library, Takashi Kanamori, 266984
A SEQUENTIAL COHORT STUDY COMPARING KAPPAMAB ALONE TO KAPPAMAB, LENALIDOMIDE AND LOW DOSE DEXAMETHASONE IN KAPPA-RESTRICTED RELAPSED REFRACTORY (RR) MULTIPLE MYELOMA (AMARC 01-16)
EHA Library, Anna KALFF, 267000
REAL WORLD DATA ON THE EFFICACY AND SAFETY OF DARATUMUMAB FOR TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY AL AMYLOIDOSIS: A MULTI-SITE RETROSPECTIVE STUDY.
EHA Library, Yael C Cohen, 267016
SURVIVAL OF MULTIPLE MYELOMA PATIENTS DIAGNOSED 1970-2015: REAL-WORLD DATA FROM A SINGLE CENTER
EHA Library, Luis Gerardo Rodríguez-Lobato, 267032
IDENTIFICATION OF THE TRUE HYPERDIPLOID MULTIPLE MYELOMA SUBSET BY COMBINING CONVENTIONAL KARYOTYPING AND FISH ANALYSIS
EHA Library, Gregorio Barilà, 267048
LIN-CD133+CD34+CD41+ HSPC REPRESENT A MEGAKARYOCYTE-PRIMED NEOPLASTIC FRACTION IN MPN PATIENTS WITH MYELOFIBROSIS
EHA Library, Vera Koehl, 267065
INTERFERON ALPHA HAS STRONG ANTI-TUMOR EFFECT IN PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
EHA Library, Patrizia Mondello, 267081
PLATELET REACTIVITY AND RESPONSE TO ANTIPLATELET DRUGS IN THROMBOCYTOPENIA AND THROMBOCYTOSIS
EHA Library, Lidia USNARSKA-ZUBKIEWICZ, 267098
INCREASED RHOA ACTIVITY DUE TO A DISRUPTED FILAMIN A/ALPHAIIBΒETA3 INTERACTION INDUCES MACROTHROMBOCYTOPENIA
EHA Library, Alessandro Donada, 267115
PARTICIPATION IN A SPECIALISED EXERCISE INTERVENTION IMPROVED PHYSICAL FUNCTION AND HEALTH-RELATED QUALITY OF LIFE IN PEOPLE WITH HAEMATOLOGICAL CANCERS
EHA Library, Jennifer Nicol, 267131
POST-TRANSPLANT CYCLOPHOSPHAMIDE IN HLA MATCHED AND HAPLOIDENTICAL TRANSPLANT RECIPIENTS RECEIVING MYELOABLATIVE TIMED SEQUENTIAL BUSULFAN CONDITIONING REGIMEN: RESULTS OF A PHASE II STUDY
EHA Library, Rohtesh Mehta, 267147
LONG-ACTING G-CSF (LIPEGFILGRASTIM, “LONQUEX”) FOR STEM CELL MOBILIZATION IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT)
EHA Library, Ivetta Danylesko, 267164
HAPLOIDENTICAL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH DETECTABLE DISEASE AT TRANSPLANT
EHA Library, Samer A. Srour, 267181
PREVALENCE AND RISK FACTORS FOR THROMBOSIS IN ADULT ITP PATIENTS TREATED WITH TPO-RA
EHA Library, Maria Lozano, 267197
AUTOIMMUNIZATION AND ALLOIMMUNIZATION IN TRANSFUSION DEPENDANT THALASSEMIA MAJOR PATIENTS:STUDY ON 300 PATIENTS
EHA Library, Ayesha younas, 267213
“3C-UP” A NEW ADULT PHILADELPHIA NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA SUBGROUP: NOVEL MOLECULAR MARKERS
EHA Library, Anna Ferrari, 267229
BLINATUMOMAB + PONATINIB FOR RELAPSED PH1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: THE FRENCH EXPERIENCE.
EHA Library, Marie-Anne COUTURIER, 267247
PHASE 1 RESULTS OF ZUMA-4: KTE-X19, AN ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY, IN PEDIATRIC AND ADOLESCENT PATIENTS WITH RELAPSED/REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Alan S. Wayne, 267263
PI3K INHIBITION COMBINED WITH STANDARD CHEMOTHERAPY EFFECTIVELY INHIBITS KIT MUTANT AML
EHA Library, Montserrat Estruch, 267280
TCF4 IS IMPORTANT FOR MUTANT RUNX1-MEDIATED CELL IMMORTALIZATION AND PREDICTS OUTCOME IN ACUTE MYELOID LEUKEMIA
EHA Library, Florentien intHout, 267297

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings